Get the Stockscreener App
8.65
1.53%
0.13
After Hours:
8.59
-0.06
-0.69%
89 Bio Inc stock is traded at $8.65, with a volume of 913.13K.
It is up +1.53% in the last 24 hours and down -1.37% over the past month.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
See More
Previous Close:
$8.52
Open:
$8.53
24h Volume:
913.13K
Relative Volume:
0.57
Market Cap:
$1.28B
Revenue:
-
Net Income/Loss:
$-174.61M
P/E Ratio:
-4.3909
EPS:
-1.97
Net Cash Flow:
$-165.54M
1W Performance:
+0.46%
1M Performance:
-1.37%
6M Performance:
+14.72%
1Y Performance:
+6.66%
1-Day Range:
$8.48
$8.71
1-Week Range:
$8.3299
$8.95
52-Week Range:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Name
89 Bio Inc
Sector
Industry
Phone
(415) 432-9270
Address
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Compare ETNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
8.65 | 1.26B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.37 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
468.58 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.20 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
763.49 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
335.67 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Resumed | H.C. Wainwright | Buy |
| Mar-14-25 | Initiated | Goldman | Neutral |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Apr-22-24 | Resumed | BofA Securities | Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-10-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-23 | Initiated | UBS | Buy |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| May-12-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-26-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Resumed | BTIG Research | Buy |
| May-25-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Apr-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-19-20 | Initiated | Raymond James | Strong Buy |
| Sep-25-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-31-20 | Initiated | Piper Sandler | Overweight |
| Jul-23-20 | Initiated | BTIG Research | Buy |
| Jul-07-20 | Initiated | Chardan Capital Markets | Buy |
| Dec-09-19 | Initiated | BofA/Merrill | Neutral |
| Dec-09-19 | Initiated | Oppenheimer | Outperform |
| Dec-09-19 | Initiated | RBC Capital Mkts | Outperform |
| Dec-09-19 | Initiated | SVB Leerink | Outperform |
View All
89 Bio Inc Stock (ETNB) Latest News
Applying big data sentiment scoring on 89bio Inc.Weekly Investment Summary & Real-Time Buy Zone Alerts - Newser
89bio Inc. stock outlook for YEAR2025 Sector Review & Safe Entry Point Alerts - Newser
Will 89bio Inc. rebound enough to break evenJuly 2025 Final Week & Real-Time Stock Price Movement Reports - Newser
Market reaction to 89bio Inc.’s recent newsEarnings Recap Summary & Entry Point Confirmation Signals - Newser
Using RSI to spot recovery in 89bio Inc.Earnings Risk Summary & Fast Entry High Yield Tips - Newser
12,272 Shares in 89BIO $ETNB Acquired by Ieq Capital LLC - Defense World
Strategies to average down on 89bio Inc.July 2025 Update & Daily Chart Pattern Signals - Newser
Smart tools for monitoring 89bio Inc.’s price actionPortfolio Growth Summary & Technical Entry and Exit Alerts - Newser
Detecting support and resistance levels for 89bio Inc.2025 Price Action Summary & Fast Entry and Exit Trade Plans - Newser
Can 89bio Inc. stock recover from recent decline2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - Newser
H.C. Wainwright Backs 89bio (ETNB) with Buy Rating - Yahoo Finance
Risk adjusted return profile for 89bio Inc. analyzedForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
89BIO (NASDAQ:ETNB) Coverage Initiated at HC Wainwright - Defense World
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech 89bio Grants 64,750 Stock Options to New Hires with 4-Year Vesting Schedule - Stock Titan
Is 89bio Inc. a cyclical or defensive stockJuly 2025 Review & Expert Verified Stock Movement Alerts - خودرو بانک
Invesco Ltd. Boosts Holdings in 89BIO $ETNB - Defense World
Is 89bio Inc. stock overvalued or fairly pricedQuarterly Earnings Report & Free Community Consensus Stock Picks - خودرو بانک
American Century Companies Inc. Acquires 71,726 Shares of 89BIO $ETNB - Defense World
Can 89bio Inc. benefit from deglobalizationJuly 2025 Technicals & High Accuracy Buy Signal Tips - خودرو بانک
Is 89bio Inc. likely to announce a buybackJuly 2025 Highlights & AI Powered Market Entry Strategies - خودرو بانک
What is 89bio Inc.’s valuation compared to sectorEarnings Overview Summary & Weekly High Potential Alerts - خودرو بانک
Is a relief rally coming for 89bio Inc. holdersJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
89bio Inc. stock daily chart insightsQuarterly Profit Summary & Precise Buy Zone Identification - Newser
What does recent volatility data suggest for 89bio Inc.Quarterly Profit Report & Community Verified Watchlist Alerts - Newser
Will 89bio Inc. benefit from macro trends2025 Price Action Summary & AI Driven Price Predictions - Newser
89bio Inc.’s volatility index tracking explainedJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - Newser
Evaluating 89bio Inc. with trendline analysisTrade Signal Summary & Free Safe Capital Growth Stock Tips - Newser
Leading vs lagging indicators on 89bio Inc. performance2025 Major Catalysts & Fast Gain Stock Tips - Newser
What moving averages say about 89bio Inc.July 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Using Bollinger Bands to evaluate 89bio Inc.July 2025 Drop Watch & Long Hold Capital Preservation Tips - Newser
89 Bio Inc Stock (ETNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):